Introduction Colorectal cancer (CRC) ranks as the third most common malignancy worldwide and the second most common cause of cancer-related deaths.1 The full implementation and popularization of CRC screening strategies in recent years have led to a significant decrease in morbidity and mortality rates in the USA and European countries.2, 3 However, the incidence of early-onset CRC (eoCRC; diagnosed < 50 years of age) has been on the rise globally.4-6 The reasons for this upward trend are not...